These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 1059467)
21. The safety and value of naloxone as a therapeutic aid. Wiesen RL; Rich CR; Wang RI; Stockdale SL Drug Alcohol Depend; 1977 Mar; 2(2):123-30. PubMed ID: 858271 [TBL] [Abstract][Full Text] [Related]
22. [Detoxification in withdrawal state in methadone maintenance patients]. Sivolap I; Savchenkov VA; Aksel'rod BA; Kubarev DA; Chichenkov TO Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(11):33-7. PubMed ID: 14681963 [TBL] [Abstract][Full Text] [Related]
23. A history of the development of narcotic antagonists for the treatment of narcotic addiction. Martin WR NIDA Res Monogr; 1978; (19):296-300. PubMed ID: 218106 [No Abstract] [Full Text] [Related]
24. Opium and heroin addicts in Laos. II. A study of matched pairs. Westermeyer J; Peng G J Nerv Ment Dis; 1977 May; 164(5):351-4. PubMed ID: 864449 [TBL] [Abstract][Full Text] [Related]
25. Narcotic antagonists: a reasonable method of treating narcotic dependency. Schooff KG; Hersch RG; Keegan JF Int J Addict; 1975; 10(3):391-400. PubMed ID: 170227 [TBL] [Abstract][Full Text] [Related]
26. A comparison of the withdrawal responses of heroin and methadone addicts during detoxification. Gossop M; Strang J Br J Psychiatry; 1991 May; 158():697-9. PubMed ID: 1860023 [TBL] [Abstract][Full Text] [Related]
27. Blockade with methadone, cyclazocine, and naloxone. Freedman AM; Zaks A; Resnick R; Fink M Int J Addict; 1970 Sep; 5(3):507-15. PubMed ID: 5524385 [No Abstract] [Full Text] [Related]
28. A clinical trial of buprenorphine: I. Comparison with methadone in the detoxification of heroin addicts. II. Examination of its opioid blocking properties. Bickel WK; Johnson RE; Stitzer ML; Bigelow GE; Liebson IA; Jasinski DR NIDA Res Monogr; 1987; 76():182-8. PubMed ID: 2449618 [No Abstract] [Full Text] [Related]
29. The role of the federal government in the development of narcotic antagonists. Green AI Adv Biochem Psychopharmacol; 1973; 8(0):576-7. PubMed ID: 4795123 [No Abstract] [Full Text] [Related]
30. Clinical aspects of the various forms of nonmedical use of drugs. I. Isbell H Anesth Analg; 1971; 50(5):886-96. PubMed ID: 5165433 [No Abstract] [Full Text] [Related]
32. [Bupropion in cigarettes smoking cessation by former polydrug user participating in methadone maintenance programme]. Steinbarth-Chmielewska K; Habrat B Przegl Lek; 2005; 62(10):1126. PubMed ID: 16521970 [TBL] [Abstract][Full Text] [Related]
37. [Drug dependence. 1. Definition, narcotic agent, mode of action and hazards]. Fischer U; Fischer B Fortschr Med; 1973 Dec; 91(34):1356-62. PubMed ID: 4797199 [No Abstract] [Full Text] [Related]
38. Rapid detoxification from opioid dependence under general anaesthesia versus standard methadone tapering: abstinence rates and withdrawal distress experiences. Krabbe PF; Koning JP; Heinen N; Laheij RJ; van Cauter RM; De Jong CA Addict Biol; 2003 Sep; 8(3):351-8. PubMed ID: 13129838 [TBL] [Abstract][Full Text] [Related]
39. Narcotic blockade--a medical technique for stopping heroin use by addicts. Dole VP; Nyswander ME; Kreek MJ Trans Assoc Am Physicians; 1966; 79():122-36. PubMed ID: 4162906 [No Abstract] [Full Text] [Related]
40. What is important in drug misuse treatment? Seivewright NA; Greenwood J Lancet; 1996 Feb; 347(8998):373-6. PubMed ID: 8598706 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]